Sponsor:
Intermountain Health Care, Inc.
Code:
NCT03579862
Conditions
Chronic Thromboembolic Pulmonary Hypertension
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Blood Draw
Brief summary:
Conditions
Chronic Thromboembolic Pulmonary Hypertension
Study ID
NCT03579862
Start date
Dec 25, 2013
Status verified date
Oct, 2022
Completion date
Dec 31, 2023
Anticipated
Primary completion date
Dec 31, 2023
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
260 participants
Anticipated
Arms
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Pulmonary Embolism (PE)
Pulmonary Arterial Hypertension (PAH)
Interventions
Blood Draw
Primary outcome measure
Central contacts
Locations
Intermountain Medical Center
Recruiting
Murray, Utah, United States, 84107
Contacts
Principal Investigator:
Mark Dodson, MD
Sponsor
Intermountain Health Care, Inc.
Last update posted
Oct 18, 2022
Last verified
Oct, 2022
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Intermountain Health Care, Inc. on 2022-10-18.